Fibrinolytic Therapy with Low-Dose Recombinant Tissue Plasminogen Activator in Retinal Vein Occlusion

Publisher： Karger

E-ISSN： 1423-0267|212|6|394-398

ISSN： 0030-3755

Source： Ophthalmologica, Vol.212, Iss.6, 1998-09, pp. : 394-398

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Visual Outcome after Treatment with Low-Dose Recombinant Tissue Plasminogen Activator or Hemodilution in Ischemic Central Retinal Vein Occlusion

By  

Ophthalmologica, Vol. 213, Iss. 6, 1999-11 ,pp. : 360-366

Karger

Access to resources Recommend Favorite

Impact of Intravitreal Injection of Tissue Plasminogen Activator on Full-Field Electroretinogram in Patients with Macular Oedema Secondary to Retinal Vein Occlusion

By  

Ophthalmologica, Vol. 226, Iss. 2, 2011-05 ,pp. : 81-86

Karger

Access to resources Recommend Favorite

Direct tissue plasminogen activator administration through a microinjection device in a pig model of retinal vein thrombosis

By Zhang Xiaoli   Ma Zhizhong   Hu Yuntao   Fan Jianguo  

Current Eye Research, Vol. 24, Iss. 4, 2002-04 ,pp. : 263-267

Informa Healthcare

Access to resources Recommend Favorite

Coagulative, Fibrinolytic and Metabolic Pattern in Patients with Central Retinal Vein Occlusion

By  

Ophthalmologica, Vol. 216, Iss. 2, 2002-04 ,pp. : 108-112

Karger

Access to resources Recommend Favorite

Intravitreal Functional Plasminogen Is Elevated in Central Retinal Vein Occlusion

By  

Ophthalmic Research, Vol. 50, Iss. 3, 2013-08 ,pp. : 151-159

Karger

Access to resources Recommend Favorite